Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > BOB IS MISSING.

<< Previous

Bullboard Posts

Next >>

Comment by wood56on Dec 07, 2021 10:22pm

169 Views

Post# 34208979

RE:BOB IS MISSING.

losingmyshirt wrote: Went past the Claritas booth at BurgerKing. Bob wasn't there. Spoke to the manager to ask when he was last seen. The fellow says he last saw Bob last week mumbling something about Let's let bygones be bygones. Was last seen heading to Value Village to buy a new suit.

A new suit? That's odd. He had a perfectly good suit that he bought at Zellers before they folded.

Maybe he has a big annoncement to make, hence the new suit.

Could it be that the rumours are true and that the will annonce the R107 infused underpants that all Claritas investors have been waiting for? We better hope so.

Hey Losing! I'll take a pair of those Clitaras infused underpants for the little woman for Christmas